Get started
Author

Amaya Virós

Observed names: A Viros, A. Viros, A. Virós, AMAYA VIRÓS, Amaya Viros, Amaya Virós Usandizaga, Viros A, Viros, A.
Observed institutions: Universitat Autònoma de Barcelona, St George's Hospital, Institute of Cancer Research, University of California, San Francisco, Salford Royal NHS Foundation Trust, Cancer Research UK, Radboud University Medical Center, University of Manchester, National Institute for Health and Care Research, Institute of Cancer Research, Reinier de Graaf Hospital, University of California San Francisco Medical Center, Salford Royal Hospital, Canisius-Wilhelmina Ziekenhuis, Royal Marsden Hospital, Vall d'Hebron Hospital Universitari, Cancer Research UK Manchester Institute, The Christie Hospital, The Christie NHS Foundation Trust, Kingston Hospital, NIHR Manchester Biomedical Research Centre, UCSF Helen Diller Family Comprehensive Cancer Center, Cancer Research UK Manchester Centre, Amsterdam UMC Location Vrije Universiteit Amsterdam
ORCID: 0000-0001-5177-5015
Observed ORCID: 0000-0001-5177-5015
OpenAlex ID: A5069648259
RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
2012 · Fei Su, Amaya Viros, et al. · New England Journal of Medicine · 1,062
PDF
Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin β1/FAK Signaling
2015 · Eishu Hirata, Maria Romina Girotti, et al. · Cancer Cell · 613
PDF
ROCK and JAK1 Signaling Cooperate to Control Actomyosin Contractility in Tumor Cells and Stroma
2011 · Victoria Sanz-Moreno, Cedric Gaggioli, et al. · Cancer Cell · 427
PDF
Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma
2012 · Maria R. Girotti, Malin Pedersen, et al. · Cancer Discovery · 397
Improving Melanoma Classification by Integrating Genetic and Morphologic Features
2008 · Amaya Viros, Jane Fridlyand, et al. · PLoS Medicine · 384
PDF
β-Catenin induces immortalization of melanocytes by suppressing p16 INK4a expression and cooperates with N-Ras in melanoma development
2007 · Véronique Delmas, Friedrich Beermann, et al. · Genes & Development · 338
PDF
Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53
2014 · Amaya Viros, Berta Sanchez-Laorden, et al. · Nature · 264
Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma
2015 · Maria Romina Girotti, Gabriela Gremel, et al. · Cancer Discovery · 237
Oncogenic BRAF Induces Melanoma Cell Invasion by Downregulating the cGMP-Specific Phosphodiesterase PDE5A
2011 · Imanol Arozarena, Berta Sanchez-Laorden, et al. · Cancer Cell · 220
Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma
2014 · Maria Romina Girotti, Filipa Lopes, et al. · Cancer Cell · 219
PDF
Analysis of the efficacy and toxicity of sorafenib in thyroid cancer: a phase II study in a UK based population
2011 · Merina Ahmed, Yolanda Barbachano, et al. · European Journal of Endocrinology · 200
Diverse matrix metalloproteinase functions regulate cancer amoeboid migration
2014 · Jose L. Orgaz, Pahini Pandya, et al. · Nature Communications · 199
PDF
Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells
2015 · Franziska Baenke, Barbara Chaneton, et al. · Molecular Oncology · 194
PDF
Gatekeeper Mutations Mediate Resistance to BRAF-Targeted Therapies
2010 · Steven Whittaker, Ruth Kirk, et al. · Science Translational Medicine · 159
Metformin Accelerates the Growth of BRAFV600E-Driven Melanoma by Upregulating VEGF-A
2012 · Matthew J. Martin, Robert Hayward, et al. · Cancer Discovery · 152
PDF
BRAF Inhibitors Induce Metastasis in RAS Mutant or Inhibitor-Resistant Melanoma Cells by Reactivating MEK and ERK Signaling
2014 · Berta Sanchez-Laorden, Amaya Viros, et al. · Science Signaling · 131
Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure
2010 · Despina Handolias, Renato Salemi, et al. · Pigment Cell & Melanoma Research · 125
Mechanisms of Drug Resistance in Melanoma
2017 · Matthew Winder, Amaya Virós · Handbook of experimental pharmacology · 115
Ultraviolet radiation–induced DNA damage is prognostic for outcome in melanoma
2018 · Lucas D. Trucco, Piyushkumar A. Mundra, et al. · Nature Medicine · 112
Lysyl oxidase drives tumour progression by trapping EGF receptors at the cell surface
2017 · HaoRan Tang, Leo Leung, et al. · Nature Communications · 95
PDF
Ultraviolet light-induced collagen degradation inhibits melanoma invasion
2021 · Timothy Budden, Caroline Gaudy-Marqueste, et al. · Nature Communications · 91
PDF
A caveolin-dependent and PI3K/AKT-independent role of PTEN in β-catenin transcriptional activity
2015 · Alejandro Conde-Perez, Gwendoline Gros, et al. · Nature Communications · 80
PDF
Primary Melanoma of the CNS in Children Is Driven by Congenital Expression of Oncogenic NRAS in Melanocytes
2013 · Malin Pedersen, Heidi V.N. Küsters-Vandevelde, et al. · Cancer Discovery · 79
Ultraviolet light and melanoma
2018 · Sarah Craig, Charles H Earnshaw, et al. · The Journal of Pathology · 57
PDF
Clinical, molecular and biochemical characterization of nine Spanish families with Conradi-Hünermann-Happle syndrome: new insights into X-linked dominant chondrodysplasia punctata with a comprehensive review of the literature
2011 · J. Cañueto, M. Girós, et al. · British Journal of Dermatology · 53
Works count: 148
Citation count: 6,525
H-index: 30
I10-index: 44
Year
Topic
Type